It is a large market with a very fragmented playing field, and so there is plenty of opportunity for us to grow our company within that market. In the longer term three to five years we will be looking at other healthcare sectors, such as devices and diagnostics to see if we can replicate our business model in those markets. I think the major risks and concerns revolve around the service nature of our business. We need to continue to diversify our client base, spreading our revenue across as many customers as possible, while at the same time, provide high-quality service and execution to all of our clients that they deserve and expect. We have been able to do that over the last two years and expect to continue to mitigate that risk even more as we move forward.
Acquisitions are an integral part of our growth strategy.
We are continually looking at potential acquisitions that complement our existing service portfolio, bring new service offerings, customers and geographic diversity. Additionally, we view the talent level of the potential acquisition as a major component or determinant to doing a deal. We are the only real pure play promotional and medical education service company in the marketplace. We think that alone gives us a competitive advantage in terms of focus and ability to execute. Most of our competitors started out as contract research or contract sales organizations and then migrated into our sector.